cyclosporine has been researched along with Hodgkin Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WC; Chen, L; Chen, R; Forman, SJ; Guo, Y; Herrera, AF; Hou, J; Kwak, LW; Mei, M; Newman, EM; Ngo, VN; Popplewell, L; Puverel, S; Rosen, ST; Song, JY; Synold, TW; Tao, S; Wu, J; Wu, X; Yi, S | 1 |
| Hoyle, C; Kazmi, M; Radia, D; Schey, SA; Streetly, M | 1 |
| Alvarez, I; Arranz, R; Caballero, D; Canales, M; Cavet, J; Garcia-Conde, J; Goldstone, AH; Hunter, A; Linch, DC; Mackinnon, S; Mahendra, P; Milligan, D; Parker, A; Peggs, KS; Qian, W; Ribera, JM; Sanz, G; Sierra, J; Sureda, A; Thomson, K; Urbano-Ispizua, A | 1 |
| Ambinder, RF; Anders, V; Bolaños-Meade, J; Borrello, IM; Brodsky, R; Flinn, IW; Fuchs, EJ; Garrett-Mayer, E; Hess, AD; Huff, CA; Jones, RJ; Kasamon, YL; Luznik, L; Matsui, W; Swinnen, LJ; Vogelsang, GB; Webb, J | 1 |
| Aggarwal, N; Batwara, R; McCarthy, ET; Savin, VJ; Sharma, M; Sharma, R | 1 |
| Hanke, C; Jüttner, E; Lauten, M; Niemeyer, CM; Pohl, M; Rohr, JC; Wacker, HH; Wagner, HJ | 1 |
| Bartoli, E; Boiocchi, M; Carbone, A; Casatta, L; De Vita, S; Dolcetti, R; Ferraccioli, GF | 1 |
| Allard, C; Benoit, S; Deschênes, G; Lamagnére, JP; Lejars, O; Nivet, H | 1 |
| Burrell, LM; Mangan, KF; Mullaney, M; Redmond, J; Reid, TJ | 1 |
| Kwen, PL; Pullicino, P; Zimmer, W | 1 |
| Shechter, P | 1 |
| Hood, IM; Mahendra, P; Marcus, RE; McNeil, K | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Allerberger, F; Gruber, J; Krugmann, J; Müller, T; Offner, FA; Sailer-Höck, M | 1 |
| Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
5 trial(s) available for cyclosporine and Hodgkin Disease
| Article | Year |
|---|---|
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Brentuximab Vedotin; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Prospective Studies; Reed-Sternberg Cells; Treatment Outcome; Xenograft Model Antitumor Assays; Young Adult | 2020 |
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Host Reaction; Hodgkin Disease; Humans; Immunologic Factors; Interferon-alpha; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Topics: Adult; Cyclosporine; Female; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Salvage Therapy; Survival Analysis; Syndrome; Transplantation Conditioning; Transplantation, Autologous | 2007 |
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine | 2000 |
12 other study(ies) available for cyclosporine and Hodgkin Disease
| Article | Year |
|---|---|
Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclosporine; Glomerular Filtration Rate; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Glomerulus; Male; Nephrosis, Lipoid; Permeability; Remission Induction | 2007 |
Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Topics: Adolescent; Antineoplastic Agents; Child; Cyclosporine; Diagnosis, Differential; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymph Nodes; Lymphoproliferative Disorders; Male | 2008 |
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Tumor Virus Infections | 1995 |
Hodgkin's disease following steroid-resistant idiopathic nephrotic syndrome.
Topics: Child; Cyclosporine; Drug Resistance; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Nephrotic Syndrome; Prednisone | 1994 |
Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietin.
Topics: Adult; Colony-Forming Units Assay; Cyclosporine; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; Hodgkin Disease; Humans; Red-Cell Aplasia, Pure; T-Lymphocytes | 1994 |
Posterior leucoencephalopathy syndrome.
Topics: Adult; Bone Transplantation; Brain; Brain Edema; Cyclosporine; Hodgkin Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Syndrome; Tacrolimus | 1996 |
Acute tubular necrosis following high-dose cyclosporine A therapy.
Topics: Adult; Cyclosporine; Drug Resistance, Multiple; Fluorescence Polarization; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Tubular Necrosis, Acute; Male | 1996 |
Hodgkin's disease after cardiac transplant: a report of two cases.
Topics: Adult; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Chlorambucil; Cyclosporine; Fatal Outcome; Heart Transplantation; Heart-Lung Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Male; Middle Aged; Myocarditis; Postoperative Complications; Prednisolone; Prednisone; Procarbazine; Tumor Virus Infections; Vinblastine | 1996 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Infant; Legionnaires' Disease; Methotrexate | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |